MedTrace Logo

Hepatocellular Carcinoma Registry in Asia: The INSIGHT Registry

NCT03233360 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2533

Last updated 2022-12-05

No results posted yet for this study

Summary

The INSIGHT ('Insight into Real-world Practice of Management of HCC in Asia-Pacific') registry is designed as a multi-centre longitudinal cohort study of patients diagnosed with HCC between 1st January 2013 and 31st December 2019 in nine countries (i.e., South Korea, Taiwan, Thailand, Japan, China, Hong Kong, Australia, New Zealand and Singapore). Approximately 30% of the sample size will be identified retrospectively and 70% will be identified prospectively from the start date of the registry (October 2016), with an even distribution of consecutively diagnosed patients within the different years.

Conditions

Sponsors & Collaborators

  • Asia-Pacific Hepatocellular Carcinoma (AHCC) Trials Group

    collaborator UNKNOWN

  • Singapore Clinical Research Institute

    collaborator OTHER

  • Iqvia Pty Ltd

    collaborator INDUSTRY

  • National Cancer Centre, Singapore

    lead OTHER

Principal Investigators

  • Pierce Chow, MD, PhD · National Cancer Centre, Singapore

Eligibility

Min Age
21 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-17
Primary Completion
2020-06-30
Completion
2020-12-31

Countries

  • Australia
  • China
  • Hong Kong
  • Japan
  • New Zealand
  • Singapore
  • South Korea
  • Taiwan
  • Thailand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03233360 on ClinicalTrials.gov